From our scRNA-seq data analysis of Meta3 and Meta4 cells, we observed expression of known cancer stem cell marker genes such as CD133 (Prom1) and CD166 (Alcam)41 in both Meta3 and Meta4 (Fig. 2c). This evidence concerns the gene PROM1 and cancer.